Remove Conditions Remove Data Remove Sleep Remove Therapy
article thumbnail

THC & CBD-Rich Cannabis for Fibromyalgia

Project CBD

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.”

THC 144
article thumbnail

Finding Hope: MMJ’s Impact on Maryland Communities

MMJ Recs

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Marijuana Legalization Associated With Decreased Sales of Sleep Aids

The Joint Blog

Legal access to marijuana is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to a new study published in the journal Complementary Therapies in Medicine. – The negative association between cannabis access and sleep aid sales suggests a consumer preference for cannabis. .

Sleep 49
article thumbnail

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

Cannabis Law Report

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). These patients also reported improved sleep and general quality of life.

article thumbnail

Vice Article: Australians Can Get a Medicinal Cannabis Prescription for Pretty Much Anything

Cannabis Law Report

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. 11 May 2022.

article thumbnail

Global Psychiatry Deals Report 2014-2021: Access to Headline, Upfront, Milestone and Royalty Data – ResearchAndMarkets.com

Cannabis Law Report

Access to headline, upfront, milestone and royalty data. Specific therapy indication. Under what conditions can the deal be terminated? Access Psychiatry deal headline, upfront, milestone and royalty data. Advanced Cooling Therapy. Trends in Psychiatry dealmaking in the biopharma industry since 2014. Admera Health.

Access 52
article thumbnail

Data is Knowledge with Otha Smith III

The Cannigma

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry.

Data 52